Washington DC –During a US Senate Finance Committee hearing on the President’s 2024 Health and Human Services (HHS) budget with Secretary Becerra, ranking member Mike Crapo (R, Idaho) undermines access and affordability to healthcare. He stressed concerns about the budget’s focus on risky partisan policies. For both current and future patients.
Crapo stresses the expansion of innovation-killing price controls contained in partisan inflation-reduction laws, congressional bipartisan scorekeepers say such expansion risks higher launch prices and distorted pricing practices. pointed out the prediction by He also noted the budget’s claim to avert the looming bankruptcy of the Medicare Hospital Insurance Trust Fund through tax increases and budgetary tactics that punish the job creators and entrepreneurs who drive the economy.
Crapo also highlighted concerns about access to accelerated-approval drugs for Medicare beneficiaries. Changes to the Medicare Advantage Risk Model. The need to protect older people’s access to telemedicine services.
On the drug pricing model that stifles the administration’s innovation:
The FDA’s expedited approval pathway has provided a lifeline to countless Americans, providing safe and effective medicines for cancer, rare diseases, and HIV, among countless other conditions such as Alzheimer’s disease. facilitated access to
Unfortunately, this administration has taken unprecedented steps to erode this pathway, stifling life-saving innovations and slowing access to healthcare. This troubling trend began with the limited coverage of CMS for an entire class of potential Alzheimer’s disease treatments and appears to continue with the recently published Accelerating Clinical Evidence model.
Secretary Becerra, I recently letter We urge governments to abandon this misguided model given, among other serious concerns, that the pipeline of new drugs for the elderly could become slower and slimmer. I also wrote to you last year about the grave implications of Alzheimer’s compensation decisions. How does your department plan to
For Proposals that Risk Disrupting Elderly Care and Raising Insurance Premiums:
CMS recently released its annual advance notice. This included several significant changes to the Medicare Advantage risk model for the upcoming bidding process. We hear multiple concerns from providers, patients, and plans that these changes will disproportionately affect the most vulnerable MA beneficiaries, including low-income individuals and those with chronic illnesses. Secretary, does the administration have these concerns and its final MA rule?
We recommend that you consider this carefully. If you have not already done so, we recommend conducting an impact analysis to determine how the model you are currently considering changing will affect the various beneficiaries. I think you’ll find that these suggestions are headed in the wrong direction.
About telemedicine expansion:
As stated in the budget request, my colleagues and I got together late last year to advance an important two-year extension of broad telemedicine flexibility, including for Medicare beneficiaries. But without further action, these policies will expire at the end of his 2024, creating a coverage cliff for tens of millions of seniors across the country.
Secretary Becerra, I know this has to involve Congress, but from your administration’s perspective, what should Medicare’s telemedicine coverage look like over the long term? Year?